← Leaderboards
Xueying Yang
University Of South Carolina At Columbia
$1,195,317
Attributed
$1,195,317
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $541.9K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,195,317 · 3
By mechanism
R21$1,195,317 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Xiaoming Li$23,837,537
- Jun Zhu$7,249,782
- Kim E Creek$3,408,301
- Saundra H Glover$719,029
- Michael Shtutman$3,559,355
Others in their field
Other Rising Stars on “Diagnosis”
- David Annett · Information Management Services, Inc.$35,571,865
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- John Alam · Eip Pharma, Inc.$10,411,018
Research focus
DiagnosisPersonsData AnalyticsSouth CarolinaViralMultiple Data SourcesCovid-19 PandemicAntiretroviral TherapyElectronic Health RecordDatabasesData SetPreventMorbidity - Disease RateSample SizeViral Load ResultCd4 Lymphocyte CountFundingGender Minority CommunityEthnic MinorityEpidemicEthnic OriginGeographic LocationsAcquired Immunodeficiency SyndromeData Sources
Grant awards (5)
Transitioning youth living with HIV to adult-oriented care: a statewide population-based study$180,446
R21 · FY2025 · HD · contact PI
Transitioning youth living with HIV to adult-oriented care: a statewide population-based study$217,865
R21 · FY2024 · HD · contact PI
Patterns and predictors of racial/ethnic disparities in HIV care continuum in the South$398,744
R21 · FY2023 · NR · contact PI
The COVID-19 vaccine efficacy among people living with and without HIV: a real-world data approach$143,171
R21 · FY2023 · AI · contact PI
The COVID-19 vaccine efficacy among people living with and without HIV: a real-world data approach$255,091
R21 · FY2022 · AI · contact PI